Science Explorer Back to mapMap
Discussion
Company · Kalamazoo · United States

Cyprotex (United States)

evotec.com/en/solutions/drug-discovery-preclinical-development/cyprotex-adme-tox-solutionsROR OpenAlex
Research works
31
▼ 60% vs 2018-21
Citations
589
19.2 per fractional work
Top-10% rate
2.5%
all institutions 10.0%
Open access
21%
world 40%
International
30%
world 18%
Cyprotex (United States)

Not ranked overall: Cyprotex (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Cyprotex (United States) work in?

In all years, 37% of research at Cyprotex (United States) is in Life Sciences, 29% in Health Sciences. Its largest fields are Medicine (22%), Biochemistry, Genetics and Molecular Biology (13%), Neuroscience (12%). It does 1.9× the world's share of Life Sciences.

Life Sciences: 11 fractional works · 37.4% of its workBiochemistry, Genetics and Molecular Biology: 4 fractional works · 13.2% of its workMolecular Biology: 2 fractional works · 7.6% of its workGenetics: 1 fractional works · 1.8% of its workCancer Research: 0 fractional works · 1.4% of its workClinical Biochemistry: 0 fractional works · 1.1% of its workBiophysics: 0 fractional works · 0.7% of its workBiotechnology: 0 fractional works · 0.6% of its workNeuroscience: 4 fractional works · 12.0% of its workCellular and Molecular Neuroscience: 4 fractional works · 11.5% of its workCognitive Neuroscience: 0 fractional works · 0.6% of its workPharmacology, Toxicology and Pharmaceutics: 2 fractional works · 5.2% of its workPharmacology: 1 fractional works · 4.1% of its workPharmaceutical Science: 0 fractional works · 0.9% of its workSmaller subfields together: 0 fractional works · 0.2% of its workAgricultural and Biological Sciences: 1 fractional works · 4.3% of its workPlant Science: 0 fractional works · 1.6% of its workAquatic Science: 0 fractional works · 1.1% of its workFood Science: 0 fractional works · 1.1% of its workAnimal Science and Zoology: 0 fractional works · 0.6% of its workImmunology and Microbiology: 1 fractional works · 2.6% of its workImmunology: 1 fractional works · 2.6% of its workHealth Sciences: 9 fractional works · 28.6% of its workMedicine: 7 fractional works · 21.5% of its workPediatrics, Perinatology and Child Health: 1 fractional works · 2.8% of its workDermatology: 1 fractional works · 2.8% of its workOncology: 1 fractional works · 2.7% of its workPulmonary and Respiratory Medicine: 1 fractional works · 2.3% of its workEndocrinology, Diabetes and Metabolism: 1 fractional works · 2.3% of its workEpidemiology: 0 fractional works · 1.4% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 1.4% of its workImmunology and Allergy: 0 fractional works · 1.1% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 1.1% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 1.0% of its workPharmacology: 0 fractional works · 0.8% of its workPsychiatry and Mental health: 0 fractional works · 0.6% of its workComplementary and alternative medicine: 0 fractional works · 0.6% of its workUrology: 0 fractional works · 0.4% of its workInfectious Diseases: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workVeterinary: 2 fractional works · 6.6% of its workSmall Animals: 2 fractional works · 6.6% of its workHealth Professions: 0 fractional works · 0.6% of its workPharmacy: 0 fractional works · 0.6% of its workPhysical Sciences: 8 fractional works · 26.4% of its workEngineering: 2 fractional works · 6.5% of its workBiomedical Engineering: 2 fractional works · 4.9% of its workElectrical and Electronic Engineering: 0 fractional works · 1.6% of its workChemistry: 2 fractional works · 5.3% of its workSpectroscopy: 1 fractional works · 2.5% of its workElectrochemistry: 0 fractional works · 1.4% of its workAnalytical Chemistry: 0 fractional works · 0.9% of its workOrganic Chemistry: 0 fractional works · 0.5% of its workComputer Science: 1 fractional works · 4.6% of its workComputational Theory and Mathematics: 1 fractional works · 4.6% of its workMathematics: 1 fractional works · 4.2% of its workStatistics and Probability: 1 fractional works · 3.8% of its workMathematical Physics: 0 fractional works · 0.4% of its workEnvironmental Science: 1 fractional works · 3.8% of its workHealth, Toxicology and Mutagenesis: 1 fractional works · 2.4% of its workWater Science and Technology: 0 fractional works · 1.1% of its workEnvironmental Chemistry: 0 fractional works · 0.4% of its workChemical Engineering: 0 fractional works · 1.4% of its workProcess Chemistry and Technology: 0 fractional works · 1.1% of its workChemical Health and Safety: 0 fractional works · 0.3% of its workMaterials Science: 0 fractional works · 0.6% of its workMaterials Chemistry: 0 fractional works · 0.6% of its workSocial Sciences: 2 fractional works · 7.6% of its workEconomics, Econometrics and Finance: 1 fractional works · 3.5% of its workEconomics and Econometrics: 1 fractional works · 3.1% of its workFinance: 0 fractional works · 0.4% of its workBusiness, Management and Accounting: 1 fractional works · 3.3% of its workAccounting: 1 fractional works · 3.3% of its workPsychology: 0 fractional works · 0.7% of its workExperimental and Cognitive Psychology: 0 fractional works · 0.7% of its workDecision Sciences: 0 fractional works · 0.2% of its workStatistics, Probability and Uncertainty: 0 fractional works · 0.2% of its workALL ITS WORKCyprotex (UnitedStates)31fractional works, all years
Life Sciences37%Physical Sciences26%Health Sciences29%Social Sciences8%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 19 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology413.2%
    2. Neuroscience412.0%
    3. Pharmacology, Toxicology and Pharmaceutics25.2%
    4. Agricultural and Biological Sciences14.3%
    5. Immunology and Microbiology12.6%
    1. Medicine721.5%
    2. Veterinary26.6%
    3. Health Professions00.6%
    1. Engineering26.5%
    2. Chemistry25.3%
    3. Computer Science14.6%
    4. Mathematics14.2%
    5. Environmental Science13.8%
    6. Chemical Engineering01.4%
    7. Materials Science00.6%
    1. Economics, Econometrics and Finance13.5%
    2. Business, Management and Accounting13.3%
    3. Psychology00.7%
    4. Decision Sciences00.2%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 1.62× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.19× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 7.65× its world share, 0 worksImmunology and Micro…Neuroscience: 2.37× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 16.97× its world share, 0 worksPharmacology, Toxico…Chemistry: 8.59× its world share, 1 worksChemistryComputer Science: 0.58× its world share, 0 worksComputer ScienceEnvironmental Science: 2.59× its world share, 1 worksEnvironmental ScienceMedicine: 1.30× its world share, 1 worksMedicineVeterinary: 14.18× its world share, 0 worksVeterinary1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 17.0×. Every wedge is a field page.

All 10 fields, with their numbers
  1. Pharmacology, Toxicology and Pharmaceutics16.97×0 works
  2. Veterinary14.18×0 works
  3. Chemistry8.59×1 works
  4. Immunology and Microbiology7.65×0 works
  5. Biochemistry, Genetics and Molecular Biology3.19×1 works
  6. Environmental Science2.59×1 works
  7. Neuroscience2.37×0 works
  8. Agricultural and Biological Sciences1.62×0 works
  9. Medicine1.30×1 works
  10. Computer Science0.58×0 works

Who are the top researchers at Cyprotex (United States)?

Ranked on the quality score, Christopher J. Strock, Jamin A. Willoughby and Jenifer A. Bradley lead among researchers whose main affiliation is Cyprotex (United States).

  1. 1 Christopher J. Strock United States · #2,310,198 worldwide 1k citations · 44 works
  2. 2 Jamin A. Willoughby United States · #2,545,783 worldwide 832 citations · 36 works
  3. 3 Jenifer A. Bradley United States · #2,808,498 worldwide 559 citations · 15 works
All ranked researchers at Cyprotex (United States)

What are the most cited papers from Cyprotex (United States)?

The most cited paper from Cyprotex (United States) is "A newin vitromethod for identifying chemical sensitizers combining peptide binding with ARE/EpRE-mediated gene expression in human skin cells" (James M. McKim, Don J. Keller, Joel R. Gorski, 2010), with 137 citations. Next come "Systematic evaluation of non-animal test methods for skin sensitisation safety assessment" (135) and "Cross-Site Reliability of Human Induced Pluripotent stem cell-derived Cardiomyocyte Based Safety Assays Using Microelectrode Arrays: Results from a Blinded CiPA Pilot Study" (134).

Most cited papers
#PaperReleasedCitations
1 A newin vitromethod for identifying chemical sensitizers combining peptide binding with ARE/EpRE-mediated gene expression in human skin cells James M. McKim, Don J. Keller, Joel R. Gorski · Cutaneous and Ocular Toxicology 24 May 2010 137
2 Systematic evaluation of non-animal test methods for skin sensitisation safety assessment Kerstin Bianca Reisinger et al. · Toxicology in Vitro Open access 30 Oct 2014 135
3 Cross-Site Reliability of Human Induced Pluripotent stem cell-derived Cardiomyocyte Based Safety Assays Using Microelectrode Arrays: Results from a Blinded CiPA Pilot Study Daniel C. Millard, Qianyu Dang, Hong Shi et al. · Toxicological Sciences Open access 26 Apr 2018 134
4 Tissue Distribution of Basic Drugs: Accounting for Enantiomeric, Compound and Regional Differences Amongst β-Blocking Drugs in Rat Trudy Rodgers, David E. Leahy, Malcolm Rowland · Journal of Pharmaceutical Sciences 27 Apr 2005 133
5 In Vitro Screening for Seizure Liability Using Microelectrode Array Technology Jenifer A. Bradley, Harry H. Luithardt, Monica R. Metea et al. · Toxicological Sciences 7 Feb 2018 100
All 83 most cited papers, with filters and sorting

Which keywords describe research at Cyprotex (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Nanomaterials, Electrode Arrays, Neural Stimulation, Biomarkers, Pharmacokinetics, Publication Bias, Animal Research Reporting and ARRIVE Guidelines.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 26 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 26 words, with their numbers
  1. Nanomaterials3▲ 13×2 topics
  2. Electrode Arrays3▲ 165×1 topic
  3. Neural Stimulation3▲ 165×1 topic
  4. Biomarkers2▲ 13×4 topics
  5. Pharmacokinetics2▲ 25×2 topics
  6. Publication Bias2▲ 126×2 topics
  7. ARRIVE Guidelines2▲ 397×1 topic
  8. Animal Research Reporting2▲ 397×1 topic
  9. Machine Learning2▲ 2.7×3 topics
  10. Risk Assessment2▲ 9.4×4 topics
  11. Bioprinting2▲ 107×1 topic
  12. Medicinal Chemistry2▲ 13×2 topics
  13. Tissue Engineering2▲ 9.1×1 topic
  14. Molecular Docking1▲ 32×1 topic
  15. Virtual Screening1▲ 65×1 topic
  16. Epidemiology1◆ 1.02×3 topics
  17. Mass Spectrometry1▲ 19×4 topics
  18. Adaptive Designs1▲ 142×1 topic
  19. False Discovery Rate1▲ 142×1 topic
  20. Health Effects1▲ 5.8×2 topics
  21. Metabolic Disorders1▲ 19×2 topics
  22. Nuclear Receptors1▲ 19×2 topics
  23. Metabolic Syndrome1▲ 3.9×3 topics
  24. Start-Up Firms1▲ 149×1 topic
  25. Transcriptional Regulation1▲ 13×3 topics
  26. Venture Capital1▲ 133×1 topic

Which research topics does Cyprotex (United States) publish most on?

By volume in 2022-now: Hormonal Regulation and Hypertension, Biosimilars and Bioanalytical Methods, Advanced Proteomics Techniques and Applications and Pesticide Residue Analysis and Safety.

Hormonal Regulation and …0Hormonal Regulation and Hypertension: 0 fractional worksBiosimilars and Bioanaly…0Biosimilars and Bioanalytical Methods: 0 fractional worksAdvanced Proteomics Tech…0Advanced Proteomics Techniques and Applications: 0 fractional worksPesticide Residue Analys…0Pesticide Residue Analysis and Safety: 0 fractional worksReceptor Mechanisms and Signaling: 0 fractional worksGeography and Environmental Studies: 0 fractional worksComputational Drug Disco…0Computational Drug Discovery Methods: 0 fractional worksDrug Transport and Resistance Mechanisms: 0 fractional worksCardiac electrophysiology and arrhythmias: 0 fractional worksNeurotransmitter Recepto…0Neurotransmitter Receptor Influence on Behavior: 0 fractional works
Endocrinology, Diabetes and MetabolismImmunologySpectroscopyFood Science6 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Hormonal Regulation and Hypertension Endocrinology, Diabetes and Metabolism 0 works
  2. 2 Biosimilars and Bioanalytical Methods Immunology 0 works
  3. 3 Advanced Proteomics Techniques and Applications Spectroscopy 0 works
  4. 4 Pesticide Residue Analysis and Safety Food Science 0 works
  5. 5 Receptor Mechanisms and Signaling Molecular Biology 0 works
  6. 6 Geography and Environmental Studies Water Science and Technology 0 works
  7. 7 Computational Drug Discovery Methods Computational Theory and Mathematics 0 works
  8. 8 Drug Transport and Resistance Mechanisms Oncology 0 works
  9. 9 Cardiac electrophysiology and arrhythmias Cardiology and Cardiovascular Medicine 0 works
  10. 10 Neurotransmitter Receptor Influence on Behavior Cellular and Molecular Neuroscience 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available20.6%not open79.4%

World: 40% of research is openly available.

with international co-authors30.5%domestic only69.5%

World: 18% is written across borders.

How has Cyprotex (United States)'s research output changed?

Output in 2022-2025 was 60% lower than in 2018-2021.

still counting20052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Cyprotex (United States) as a percentage of every work published that year, 0.000039% in 2024.

still counting0.000050%0.00010%0.00015%Cyprotex (United States)0.0000012% in 202520102020

Fractional works of Cyprotex (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Kalamazoo

All research institutions in Kalamazoo

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Cyprotex (United States). Posts are plain text and can be reported.